TCM
ARRY

TimesSquare Capital Management’s Array Biopharma Inc ARRY Stock Holding History

TimesSquare Capital Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-3,639,989
Closed -$16.6M – 258
2015
Q3 		$16.6M Sell
3,639,989
-145,106
-4% -$860K 0.1% 210
2015
Q2 		$27.3M Sell
3,785,095
-21,655
-0.6% -$160K 0.15% 197
2015
Q1 		$28.1M Sell
3,806,750
-285,700
-7% -$2.03M 0.15% 199
2014
Q4 		$19.4M Buy
4,092,450
+152,600
+4% +$604K 0.11% 209
2014
Q3 		$14.1M Buy
3,939,850
+65,900
+2% +$260K 0.08% 223
2014
Q2 		$17.7M Sell
3,873,950
-53,550
-1% -$221K 0.1% 214
2014
Q1 		$18.5M Sell
3,927,500
-61,700
-2% -$310K 0.1% 214
2013
Q4 		$20M Buy
3,989,200
+2,524,400
+172% +$13.7M 0.1% 209
2013
Q3 		$9.11M Buy
+1,464,800
New +$8.7M 0.05% 226

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

TimesSquare Capital Management's ARRY Position: Q4 2015 in Review

TimesSquare Capital Management sold out of Array Biopharma Inc (ARRY) in Q4 2015, closing a stake of 3,639,989 shares — an estimated $16.6M sold.

TimesSquare Capital Management first reported a position in ARRY in Q3 2013 and held it in 9 quarters. The position peaked at $28.1M in Q1 2015. 151 funds tracked by Wall St. Rank hold ARRY as of Q4 2015.

  • TimesSquare Capital Management reported no remaining Array Biopharma Inc position as of Q4 2015 after selling out during the quarter.
  • TimesSquare Capital Management sold 3,639,989 Array Biopharma Inc shares in Q4 2015, an estimated $16.6M.
  • TimesSquare Capital Management first reported a position in Array Biopharma Inc in Q3 2013 and held it in 9 quarters.
  • TimesSquare Capital Management's Array Biopharma Inc position peaked at $28.1M in Q1 2015.
  • 151 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q4 2015.

Based on TimesSquare Capital Management's 13F filing for Q4 2015, filed 11 Feb 2016.